StockData
Alpha Cognition Inc. logo

Alpha Cognition Inc. (ACOG) stock

ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3064% above fair value
$8.60+0.68 (+8.59%)

Close on Nov 18, 2026Market cap $187.29MP/E –Yield –

Alpha Cognition operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Alpha Cognition's operating income for the twelve months ending Jun 30, 2026 was -$29.09M. For fiscal 2025 it was -$22.66M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.66M–
FY2024Dec 31, 2024-$12.01M–
FY2023Dec 31, 2023-$9.94M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.76M–
Q1 FY2026Mar 31, 2026-$8.10M–
Q4 FY2025Dec 31, 2025-$7.93M–
Q3 FY2025Sep 30, 2025-$5.31M–
Q2 FY2025Jun 30, 2025-$8.45M–
Q1 FY2025Mar 31, 2025-$3.40M–
Q4 FY2024Dec 31, 2024-$2.69M–
Q3 FY2024Sep 30, 2024-$2.49M–
Q2 FY2024Jun 30, 2024-$2.42M–
Q1 FY2024Mar 31, 2024-$4.41M–
Q4 FY2023Dec 31, 2023-$2.42M–
Q3 FY2023Sep 30, 2023-$2.77M–
Q2 FY2023Jun 30, 2023-$2.73M–

More Alpha Cognition figures

See a number that looks wrong?